YSP Southeast Asia Holding Bhd - Asset Resilience Ratio
YSP Southeast Asia Holding Bhd (7178) has an Asset Resilience Ratio of 27.37% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See YSP Southeast Asia Holding Bhd (7178) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2024)
This chart shows how YSP Southeast Asia Holding Bhd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see YSP Southeast Asia Holding Bhd asset portfolio.
Liquid Assets Composition Over Time
This chart breaks down YSP Southeast Asia Holding Bhd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 7178 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | RM148.10 Million | 27.37% |
| Short-term Investments | RM0.00 | 0% |
| Total Liquid Assets | RM148.10 Million | 27.37% |
Asset Resilience Insights
- Very High Liquidity: YSP Southeast Asia Holding Bhd maintains exceptional liquid asset reserves at 27.37% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
YSP Southeast Asia Holding Bhd Industry Peers by Asset Resilience Ratio
Compare YSP Southeast Asia Holding Bhd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Beijing Tongrentang Co Ltd
SHG:600085 |
Drug Manufacturers - Specialty & Generic | 0.50% |
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Neuland Laboratories Limited
NSE:NEULANDLAB |
Drug Manufacturers - Specialty & Generic | 9.65% |
|
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062 |
Drug Manufacturers - Specialty & Generic | 1.18% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.01% |
Annual Asset Resilience Ratio for YSP Southeast Asia Holding Bhd (2016–2024)
The table below shows the annual Asset Resilience Ratio data for YSP Southeast Asia Holding Bhd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 15.16% | RM80.14 Million ≈ $20.12 Million |
RM528.74 Million ≈ $132.75 Million |
+5.28pp |
| 2023-12-31 | 9.87% | RM51.41 Million ≈ $12.91 Million |
RM520.74 Million ≈ $130.74 Million |
-17.45pp |
| 2022-12-31 | 27.32% | RM129.51 Million ≈ $32.51 Million |
RM474.05 Million ≈ $119.02 Million |
+0.43pp |
| 2021-12-31 | 26.89% | RM120.40 Million ≈ $30.23 Million |
RM447.75 Million ≈ $112.42 Million |
+17.54pp |
| 2020-12-31 | 9.35% | RM41.94 Million ≈ $10.53 Million |
RM448.74 Million ≈ $112.66 Million |
-2.11pp |
| 2019-12-31 | 11.46% | RM49.47 Million ≈ $12.42 Million |
RM431.74 Million ≈ $108.39 Million |
+0.72pp |
| 2018-12-31 | 10.74% | RM44.28 Million ≈ $11.12 Million |
RM412.41 Million ≈ $103.54 Million |
-9.59pp |
| 2017-12-31 | 20.32% | RM75.20 Million ≈ $18.88 Million |
RM370.01 Million ≈ $92.90 Million |
+9.54pp |
| 2016-12-31 | 10.79% | RM36.80 Million ≈ $9.24 Million |
RM341.10 Million ≈ $85.64 Million |
-- |
About YSP Southeast Asia Holding Bhd
Y.S.P. Southeast Asia Holding Berhad, together with its subsidiaries, engages in the manufacturing and trading of generic drugs in Malaysia, Singapore, Vietnam, Philippines, Cambodia, Myanmar, Brunei, Indonesia, Thailand, Africa, and internationally. It operates through three segments: Manufacturing, Trading, and Investment Holding. The company manufactures, sells, imports, exports, trades in, an… Read more